Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BHC
- Price
- 4.32
- Stock movement down
- -0.05 (-1.14%)
- Company name
- Bausch Health Companies Inc
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 1.59B
- Ent value
- 27.65B
- Price/Sales
- 0.17
- Price/Book
- -
- Div yield
- 8.46%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 6.20
- Forward P/E
- 1.01
- PEG
- -
- EPS growth
- -32.82%
- 1 year return
- -51.57%
- 3 year return
- -42.76%
- 5 year return
- -21.88%
- 10 year return
- -31.82%
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 0.37 |
| Dividend yield | 8.46% |
| Payout frequency | - |
| Maximum yield | 8.46% |
| Average yield | 3.53% |
| Minimum yield | 1.06% |
| Discount to avg yield | 58.33% |
| Upside potential | 139.99% |
| Yield as % of max yield | 100.00% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 8.46% |
| Current yield distribution | - |
| Yield at 100% (Min) | 1.06% |
| Yield at 90% | 1.28% |
| Yield at 80% | 1.46% |
| Yield at 50% (Median) | 4.16% |
| Yield at 20% | 5.07% |
| Yield at 10% | 5.59% |
| Yield at 0% (Max) | 8.46% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | - |
| CCC status | - |
| Dividend per share | 0.37 |
| Payout frequency | - |
| Ex-div date | 11 Jun 2014 |
| EPS (TTM) | 0.70 |
| EPS (1y forward) | 4.28 |
| EPS growth (5y) | -32.82% |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| BHC | S&P500 | |
| DGR MR | 5.54% | -13.74% |
| DGR TTM | -61.44% | 6.60% |
| DGR 3 years | 10.54% | 5.24% |
| DGR 5 years | - | 5.40% |
| DGR 10 years | - | 7.07% |
| DGR 15 years | - | 6.12% |
| Time since last change announced | - |
| EPS growth (5y) | -32.82% |
| EPS growth (5y forward) | - |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | - | - |
| Average | - | - |
| Forward | 8.55% | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 6.20 |
| Price to OCF | 1.15 |
| Price to FCF | 1.57 |
| Price to EBITDA | 451.55 |
| EV to EBITDA | 7858.33 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.17 |
| Price to Book | - |
| EV to Sales | 2.92 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 367.80M |
| EPS (TTM) | 0.70 |
| FCF per share (TTM) | 2.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 9.46B |
| Gross profit (TTM) | 8.40B |
| Operating income (TTM) | 1.40B |
| Net income (TTM) | 256.29M |
| EPS (TTM) | 0.70 |
| EPS (1y forward) | 4.28 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 88.77% |
| Operating margin (TTM) | 14.78% |
| Profit margin (TTM) | 2.71% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 719.00M |
| Net receivables | 2.09B |
| Total current assets | 5.35B |
| Goodwill | 11.17B |
| Intangible assets | 5.65B |
| Property, plant and equipment | 0.00 |
| Total assets | 26.54B |
| Accounts payable | 667.00M |
| Short/Current long term debt | 21.51B |
| Total current liabilities | 4.51B |
| Total liabilities | 26.78B |
| Shareholder's equity | -242.00M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 1.39B |
| Capital expenditures (TTM) | 375.00M |
| Free cash flow (TTM) | 1.01B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | 0.97% |
| Return on Invested Capital | 1.21% |
| Cash Return on Invested Capital | 4.75% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.37 |
| Daily high | 4.45 |
| Daily low | 4.25 |
| Daily Volume | 2.28M |
| All-time high | 262.52 |
| 1y analyst estimate | 8.57 |
| Beta | 0.74 |
| EPS (TTM) | 0.70 |
| Dividend per share | 0.37 |
| Ex-div date | 11 Jun 2014 |
| Next earnings date | 30 Apr 2025 |
Downside potential
Loading...
Downside potential data
| BHC | S&P500 | |
| Current price drop from All-time high | -98.35% | -12.89% |
| Highest price drop | -98.35% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -59.52% | -11.07% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 3180 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.59B
Marketcap category
Small-cap
Description
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Employees
20270
Website
Investor relations
-
SEC filings
CEO
Joseph C. Papa
Country
USA
City
Laval
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page